Skip to main content
. 2020 Dec 21;6(1):606–614. doi: 10.1021/acsomega.0c05102

Figure 6.

Figure 6

Binding interaction of (−)-kusunokinin and other inhibitors/substrates with AKR1B1. Six compounds were chosen for MD simulation: (−)-kusunokinin (a), zenarestat (b), minalrestat (c), epalrestat (d), UVI2008 (e), and prostaglandin H2 (PGH2) (f). The black, red, and green dotted lines represent hydrogen bonds, π–π interaction, and π–alkyl interaction, respectively.